Combination SGLT2 inhibitor and GLP-1 receptor agonist therapy: a complementary approach to the treatment of type 2 diabetes
-
- Robert S. Busch
- Albany Medical Center Division of Community Endocrinology, Albany, NY, USA
-
- Michael P. Kane
- Department of Pharmacy Practice, Albany College of Pharmacy and Health Sciences, Albany, NY, USA
収録刊行物
-
- Postgraduate Medicine
-
Postgraduate Medicine 129 (7), 686-697, 2017-06-28
Informa UK Limited
